Multiple Sclerosis at the Limits 2024

Roche

Roche Products Limited has provided financial support for this meeting but has had no involvement in the agenda or the organisation of this meeting other than the Roche symposium.

Neuraxpharm

Neuraxpharm has contributed to the funding of this meeting by way of sponsorship and has had no control or input into the educational content of this activity, nor the logistics elements, i.e. travel, accommodation, catering, venue selection or any other aspect of the meeting, except for the agenda, content and speakers of their symposium which have been designed by Neuraxpharm.

Novartis

Novartis has contributed to the funding of this meeting by way of sponsorship and has had no control or input into the educational content of this activity, nor the logistics elements, i.e. travel, accommodation, catering, venue selection or any other aspect of the meeting.

Sanofi

Sanofi has supported this meeting through financial sponsorship and has had no control or input into the education content of this activity, nor the logistics elements, i.e. travel, accommodation, catering, venue selection or any other aspect of the meeting.

Disclosure of funders is made once contracts are signed and pre-event obligations such as payment have been completed.